ERR agonist in metabolic syndrome
Tested SLU-PP-332 in diet-induced obesity model.
Reduced body weight and fat mass with improved glycemic control.

Pan-ERR agonist mimicking endurance-exercise signaling.
SLU-PP-332 is a pan-agonist of the estrogen-related receptors (ERRα/β/γ) studied as an exercise-mimetic for metabolic and endurance research.
Activates ERR transcriptional programs governing mitochondrial biogenesis, fatty-acid oxidation and oxidative-fiber gene expression.
Peptide engages target receptor with high affinity.
Downstream intracellular pathways activate.
Gene expression and protein synthesis shift.
Measurable change in the studied biomarker.
Tested SLU-PP-332 in diet-induced obesity model.
Reduced body weight and fat mass with improved glycemic control.
Quantified endurance performance under SLU-PP-332 without training.
Significant increase in running time and distance vs. vehicle.
Reviewed ERRα/γ biology relevant to ERR-agonist class.
Established ERR pathway as central regulator of oxidative-fiber metabolism.
Store at -20°C, desiccated and light-protected.
Strictly for in-vitro laboratory and research investigations.
Not approved for diagnostic, therapeutic, or veterinary application.
Handling restricted to licensed researchers and laboratory staff.
Warning — SLU-PP-332 is supplied solely for legitimate laboratory research. Any administration to humans or animals is strictly prohibited and may violate federal, state, or local law. By purchasing, the researcher accepts full responsibility for safe handling, storage, and lawful use.